IBI376

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IBI376, covering 2023-05-12 to 2024-06-05. Get the full timeline:

Most recent: Clinical Trial Update: IBI376 in Patients With Relapsed or Refractory Follicular Lymphoma/Marginal Zone Lymphoma [Phase 2]